Members of the Hsp90 family of molecular chaperones play important roles in allowing some intracellular signaling molecules and transcription factors to reach and maintain functionally active conformations. In the present study, we have utilized the specific Hsp90-binding agent, geldanamycin, to examine the requirement for Hsp90 during zebrafish development. We show that geldanamycin interacts with both the ␣ and the ␤-isoforms of zebrafish Hsp90 and that geldanamycin-treated embryos consistently exhibit a number of defects in tissues which express either one of these genes. Within the somites, geldanamycin treatment results in the absence of eng-2-expressing muscle pioneer cells. However, early development of adaxial cells, which give rise to muscle pioneers and which strongly express the hsp90␣ gene shortly before muscle pioneer formation, appeared unaffected. Furthermore, development of the notochord, which provides many of the signals required for proper somite patterning and which does not express detectable levels of either hsp90␣ or hsp90␤ mRNA, was similarly unaffected in geldanamycin-treated embryos. The data are consistent with there being a temporal and spatial requirement for Hsp90 function within somitic cells which is necessary for the formation of eng-2-expressing muscle pioneers and possibly other striated muscle fiber types.
INTRODUCTION
Numerous biochemical and cell culture studies have shown that members of the highly conserved Hsp90 3 family of molecular chaperones interact with and modulate the activity of several important cellular signaling molecules and transcription factors such as steroid receptors (Catelli et al., 1985; Sanchez et al., 1985; Pratt, 1992 Pratt, , 1993 Smith and Toft, 1993), pp60 v-src kinase (Schuh et al., 1985; Brugge, 1986) , and the myogenic bHLH protein MyoD (Shaknovich et al., 1992; Shue and Kotz, 1994) . Genetic studies in yeast have extended these observations to show that Hsp90 plays a role in signal transduction cascades in vivo. For example, reduction in the activity or levels of Hsp90 in Saccharomyces cerevisiae specifically compromise the activity of mammalian glucocorticoid receptor and pp60 v-src in strains which express these two signaling molecules (Picard et al., 1990; Bohen and Yamamoto, 1993; Xu and Lindquist, 1993; Nathan and Lindquist, 1995; Nathan et al., 1997) . Recent data suggest that the apparent specificity of Hsp90 for only a small subset of cellular proteins may be due to its role in stabilization of otherwise inherently unstable conformations which some signaling molecules exhibit (reviewed in Csermely et al., 1998) .
Complex spatial and temporal patterns of hsp90 gene expression have been reported during embryogenesis in a variety of vertebrate and nonvertebrate animal systems (Morange, 1997a,b) . For example, maternally synthesized hsp83 mRNA in Drosophila embryos is localized to the posterior pole by a novel mechanism which involves general degradation throughout the embryo and localized pro-tection at the posterior (Ding et al., 1993;  hsp83 is the single member of the Hsp90 gene family in Drosophila). In contrast, zygotic expression of the hsp83 gene is localized specifically to the anterior pole and may be regulated by the anterior morphogen bicoid (Ding et al., 1993) . Studies such as these have led to the suggestion that Hsp90 plays fundamentally important roles during early embryonic development. In this light, the capacity of Hsp90 to act in a regulatory fashion in intracellular signaling pathways is particularly intriguing and work in Drosophila suggests that it may play a similar role within the developing embryo. For example, heterozygous mutations in the Drosophila hsp83 gene impair signaling by the sevenless receptor protein tyrosine kinase, which is required for determination of the R7 photoreceptor neuron during development of the compound eye (Cutforth and Rubin, 1994) , and inhibit embryonic Raf-mediated signaling (van der Straten et al., 1997) . More recently, Rutherford and Lindquist (1998) have put forth the intriguing hypothesis that Hsp90's role in embryonic signal transduction cascades may allow it to function as a molecular mechanism which links the process of evolutionary change in Drosophila embryos to environmental stress.
Our laboratory has been examining the expression and function of heat shock proteins during early embryonic development of the zebrafish (Krone and Sass, 1994; Pearson et al., 1996; Sass et al., 1996; Krone et al., 1997) . We have previously shown that the zebrafish members of two heat shock gene families, namely hsp47 and hsp90, exhibit complex spatial and temporal patterns of expression and, importantly, that they are coexpressed with genes encoding putative targets of their chaperoning activity Sass et al., 1996) . The latter study provided the first evidence which established a strong link between hsp90 gene expression and the process of myogenesis in vivo and demonstrated strong constitutive hsp90␣ expression in developing muscle cells within the somites of early embryos (vertebrates synthesize two closely related members of the Hsp90 family known as Hsp90␣ and Hsp90␤; reviewed in Gupta, 1995) . Both the hsp90␣ and the myoD genes are concomitantly down-regulated following differentiation of these cells into striated fibers. In addition, we have recently reported that expression of hsp90␣ mRNA is enriched in developing chicken somites . These studies strongly suggested that the hsp90␣ gene may play a role in the normal process of myogenesis and were particularly interesting in light of studies which had reported the interaction of mammalian Hsp90 with several signaling molecules and transcription factors important to vertebrate skeletal muscle development (Miyata and Yahara, 1992; Shaknovich et al., 1992; Shue and Kohtz, 1994; Johnson et al., 1996) .
Despite extensive analysis of Hsp90 expression during vertebrate embryogenesis, a temporal requirement for Hsp90 function during development of any one cell type within the context of the whole vertebrate embryo has not been demonstrated. Studies of Hsp90 function during vertebrate embryogenesis are complicated by several factors. These include the multigene nature of the vertebrate hsp90 family, including the presence of several pseudogenes (Gupta, 1995) , and the fact that Hsp90 probably plays multiple roles at different time points during development. Thus, traditional loss-of-function methodologies for the assessment of embryonic gene function such as microinjection and gene knockouts, which usually target only the first major developmental event in which a gene is involved, will typically result in early lethality for hsp90. Recently, the fungal benzoquinoid ansamycin geldanamycin (GA), which was originally identified as a naturally occurring antitumor agent (DeBoer et al., 1970) , has been shown to interact in a specific manner with Hsp90 in a number of organisms (Whitesell et al., 1994; Smith et al., 1995; Whitesell and Cook, 1995; Stebbins et al., 1997) . GA appears to interact with the ATP-binding domain of Hsp90 (Grenert et al., 1997; Prodromou et al., 1997; Sullivan et al., 1997) and, importantly, causes a specific loss of function to a number of Hsp90-dependent signal transduction proteins both in vitro and in vivo (Schulte et al., 1995 (Schulte et al., , 1996 Hartson et al., 1996; Thulasiraman and Matts, 1996; Uma et al., 1997; Czar et al., 1997; Dittmar and Pratt, 1997; Segnitz and Gehring, 1997; Stancato et al., 1997) . As well, the crystal structure of the Hsp90/GA complex has now been published (Stebbins et al., 1997) . Importantly, conserved amino acid residues of Hsp90 in a diverse variety of species are clustered around the GA binding pocket and previously characterized functional mutations in yeast and Drosophila Hsp90 map to either this pocket or the immediate vicinity of it (Stebbins et al., 1997) . The establishment of GA as a specific inhibitor of Hsp90 has allowed questions regarding the function of this protein in vivo to be addressed in eukaryotic cells which were previously only possible in yeast. In the present study, we have utilized GA to examine the requirement for Hsp90 during the early development of zebrafish embryos.
MATERIALS AND METHODS

Embryo Manipulation and Treatment
Adult zebrafish were maintained according to standard methods (Westerfield 1995) and staged as described by Kimmel et al. (1995) . Geldanamycin, geldampicin, or forskolin was dissolved in 100% DMSO and stored in the dark at Ϫ20°C. Manually dechorionated embryos were incubated in system water with 20 g/ml GA or geldampicin or 250 M forskolin and photographed using a Zeiss Photomicroscope with Normarski optics. Controls in all experiments consisted of embryos incubated in system water only and in system water containing DMSO at the same concentration as treatment groups. Higher concentrations of GA were lethal, whereas treatment at 5 or 10 g/ml resulted in a reduction in severity of the phenotype (see Results). Similarly, concentrations of forskolin below 250 M reduced the severity of the observed phenotype, whereas those above 500 M resulted in increased lethality.
GA-Affinity Chromatography
Lysates obtained from adult trunks were adjusted to approximately 2 mg/ml protein and preincubated with either soluble GA (30 g/ml) or DMSO (vehicle control) for 3 h at 4°C. Lysates were clarified by brief centrifugation and incubated in the presence of nonderivatized or GA-derivatized resin for 3 h and washed five times with lysis buffer. GA resins were prepared as previously described (Whitesell et al., 1994) and blocked for 1 h in 10 mM Pipes ⅐ NaOH, 150 mM NaCl, 0.05% Tween 20, 10 mg/ml BSA, pH 7.0, prior to use. Bound materials were eluted by boiling in SDS-PAGE sample buffer and were separated by SDS-PAGE. Eluted proteins were visualized by silver staining or Western blotting using anti-Hsp90 antiserum (Ullrich et al., 1986) .
Rabbit reticulocyte lysates were used for coupled transcription/ translation protein synthesis (Craig et al., 1992) in reactions programmed with the plasmid pCS2 ϩ (gift from R. Rupp) containing either the zebrafish hsp90␣ or hsp90␤ cDNA. These cDNAs, which are described fully elsewhere (Lele et al., unpublished data; GenBank Accession Nos. AF068772 and AF068773), were isolated from a postsomitogenesis embryonic library (gift from D. Grunwald, R. Riggleman, and K. Helde) using the previously described PCR-generated zebrafish hsp90␣ and hsp90␤ cDNA fragments as probes (Krone and Sass, 1994) . Reactions containing 35 S-labeled Hsp90 were preincubated with either soluble GA (50 g/ml) or DMSO (vehicle control) prior to incubation with the GA resin for 1 h. After binding, GA resins were washed three times with 10 mM Pipes ⅐ NaOH, 150 mM NaCl, 0.05% Tween 20, pH 7.0. Materials remaining bound to the GA resin were subsequently eluted by boiling in SDS-PAGE sample buffer, analyzed by reducing SDS-PAGE on 8% gels, and detected using autoradiography.
Whole-Mount in Situ Hybridization
Digoxigenin-11-UTP (Boehringer Mannheim) labeled sense and antisense RNA probes were synthesized by in vitro transcription. The in situ hybridization protocol of Puschel et al. (1992) was used with minor modifications (Akimenko et al., 1994; Sass et al., 1996; . As templates, we used the previously described cDNAs encoding zebrafish myoD , col2a1 (Yan et al., 1995) , ␣-tropomyosin (gift from R. Riggleman), sonic hedgehog (shh; Krauss et al., 1993) , echidna hedgehog (ehh; Currie and Ingham, 1996) , engrailed-2 (eng-2; Ekker et al., 1992) , axial (Strahle et al., 1993) , and no tail (ntl; Schulte-Merker et al., 1994a,b) .
RESULTS
Zebrafish Hsp90s Bind in a Specific and Competable Manner to Geldanamycin
To determine whether zebrafish Hsp90s interact with GA and whether other zebrafish proteins also bind GA, GAaffinity assays were performed with extracts prepared from adult zebrafish tissues. Numerous studies have shown that a wide range of vertebrate cell types both in vivo and in culture express both the ␣ and the ␤ isoforms of Hsp90 to varying degrees under nonstress conditions (see Morimoto et al., 1994 , for reviews). Furthermore, we have found that, while muscles of the trunk significantly down-regulate hsp90␣ gene expression following their formation (Sass et al., 1996) , expression of both hsp90␣ and hsp90␤ is detectable using Northern blot analysis during late stages of embryogenesis and in adult tissues and cultured zebrafish cells (data not shown). As shown in Fig. 1A , only a single zebrafish protein is observed to bind to GA-derivatized resin in a competable fashion. This GA-binding protein had an apparent MW of 90 kDa and was thus speculated to represent one or more zebrafish Hsp90 isoforms.
To confirm this identification, proteins recovered from GA-binding reactions were analyzed by Western blotting with polyclonal antiserum raised against mouse Hsp90 (Ullrich et al., 1986) . This anti-Hsp90 antiserum recognizes a 90-kDa protein occurring in unfractionated zebrafish lysates and which is retained on GA resins in a specific (competable) fashion (Fig. 1B) . No other proteins were observed to be specifically bound to the GA resin (Fig. 1A) . Because protein extracts derived from early embryos consisted predominantly of a 90-to 110-kDa protein (tentatively identified as the yolk cleavage product of vitellogenin (Selman et al., 1993 ; data not shown)) which severely compromised electorphoretic analyses, such assays using lysates derived from zebrafish embryos were not feasible. Nonetheless, assays with lysates from adult tissues detected a 90-kDa protein with antigenic similarity to mam- malian Hsp90 that bound to GA resins in a specific (competable) fashion, suggesting that one or more zebrafish Hsp90s bind specifically to GA.
To confirm that both zebrafish Hsp90 isoforms bind to GA, zebrafish Hsp90␣ and Hsp90␤ were translated in rabbit reticulocyte lysate, concomitantly radiolabeled with [
35 S]methionine, and subsequently analyzed on highresolution SDS-PAGE gels. Translation reactions programmed with template for Hsp90␤ synthesized a single 35 S-labeled gene product whose M r was consistent with its identity as zebrafish Hsp90␤ ( Fig. 2A) . Reactions programmed with message for Hsp90␣ similarly synthesized 35 S-labeled zebrafish Hsp90␣, although some minor translation products were also observed ( Fig. 2A) . Importantly, when zebrafish 35 S-labeled Hsp90 gene products were assayed for binding to immobilized GA, both Hsp90␣ and Hsp90␤ were observed to bind to immobilized GA in a specific, competable fashion (Fig. 2B ). This specific binding was consistent with numerous demonstrations that Hsp90s from various species bind specifically to GA (see Introduction). Furthermore, comparison of the deduced zebrafish Hsp90␣ and Hsp90␤ sequences to the groups of amino acid residues which make up the human Hsp90 GA-binding pocket (Stebbins et al., 1997) revealed 98 and 92% identity, respectively (data not shown). Importantly, the two zebrafish proteins exhibit complete conservation of those amino acid residues in and around the GA-binding pocket which are also conserved in the amino-terminal domains of Hsp90 from diverse species such as yeast, Drosophila, and human (Stebbins et al., 1997) . Given this amino acid identity and the results presented in Fig. 2 , we conclude that both Hsp90␣ and Hsp90␤ from zebrafish interact with GA in a specific manner. While these data do not allow us to unequivocally conclude that the embryonic forms of Hsp90 also interact with GA, the data presented below strongly suggest that such an interaction occurs in GAtreated embryos.
Geldanamycin Treatment of Zebrafish Embryos Gives Rise to a Characteristic Phenotype
To examine the effects of GA treatment on zebrafish development, embryos were incubated in a solution of GA in system water. GA treatment initiated at the midblastula stage was rapidly lethal in over 95% of the embryos with the few that survived exhibiting developmental arrest during gastrulation (data not shown). This is consistent with the expression pattern of the hsp90␤ gene, which is detectable in all cells of late blastula-and early gastrula-stage embryos following the midblastula transition (Figs. 4A and 4B) . When the same treatment was initiated later in development following the onset of gastrulation, the death rate of embryos up to 20 h of age was comparable to that observed in either DMSO-treated or untreated controls (Table 1) . However, 78% of the embryos exhibited a predominant phenotype characterized by a shortened trunk and tail, aberrations in somite shape and size, and a lack of yolk tube extension below the developing tail (Table 1; Fig.  5, compare 5A, 5C, and 5E with 5B, 5D, and 5F). The aberrations in somite shape and size were most prominent in the caudal portion of the trunk and in the tail (compare somites at arrow in Figs. 5C and 5D and asterisks in 5E and 5F). The total number of somites which formed in GAtreated embryos was 75-85% of controls. Most of the embryos died by about 24 h of age. When treatment was initiated later in development following the onset of anterior somite formation, we observed a reduction in both the incidence and the severity of the phenotype, with effects being confined primarily to the caudal portion of the tail.
To ensure that the defects were due specifically to geldanamycin and not a more general effect of benzoquinone ansamycins, we carried out parallel experiments using geldampicin. Geldampicin is identical to geldanamycin except for a single side-chain substitution (Whitesell et al., 1994) . However, the competition efficiency of free geldampicin in Hsp90-binding assays using GA-derivatized resins is approximately two orders of magnitude below that of free GA, a result which is consistent with the difference in the abilities of these two compounds to inhibit the activity of specific Hsp90 substrates (Whitesell et al., 1994; Grenert et al., 1997) . In agreement with these studies, we could detect no phenotypic differences between control embryos and those treated with geldampicin beginning at 50% epiboly (Table 1) . This confirmed that the GA-induced phenotype was not due to a general effect of benzoquinone ansamycins and, furthermore, suggested that it arose from a specific GA/Hsp90 interaction in treated embryos.
Embryos exposed to GA also exhibited several other abnormalities. The embryos did not extend around the yolk but rather remained on top of it, even though the cell movements of epiboly which engulf the yolk were completed. In the small proportion of less severely affected embryos, which grew until 2 days of age, pigmentation was dramatically reduced, the eyes were smaller, and the forebrain and midbrain did not appear to develop fully. These embryos also displayed defects in the development of the circulatory system. Thus, despite the presence of a beating heart, proper circulation was never established. Perhaps due to the lack of circulation, cells in the tails of these mildly affected embryos eventually became necrotic and the embryos died. The GA-induced defects are consistent with the constitutive expression patterns of the hsp90␣ and hsp90␤ genes. The hsp90␤ gene is expressed in the developing brain, tail bud, cells surrounding the posterior margin of the yolk tube, and several other tissues ( Fig. 4 ; Sass et al., 1996) . In contrast, the hsp90␣ gene is strongly expressed in early embryos within the somitic slow muscle progenitors known as adaxial cells, which lie immediately adjacent to the notochord (solid arrow in Fig. 3 ; Sass et al., 1996) . In other work, we have found that the hsp90␣ gene is also strongly expressed during the early differentiation of fast fibers, which form later during development at a time when the gene has already been down-regulated in the formed slow muscle fibers (C. C. Martin and P. H. Krone, unpublished) . The somitic phenotype induced by GA was particularly interesting in relation to the expression of hsp90␣ in developing muscle cells and is explored in subsequent sections of this study. 
Development of the Notochord in the Trunk and Tail of GA-Treated Embryos
The somitic phenotype induced by GA is similar to that previously described for embryos which fail to form a notochord when carrying homozygous mutations in the ntl (Halpern et al., 1993) and floating head (flh; Halpern et al., 1995; Talbot et al., 1995) genes. To monitor notochord formation, we initially utilized a zebrafish col2a1 antisense probe which detects type II collagen mRNA (Yan et al., 1995) . This mRNA is expressed in a spatiotemporal wave during formation of the notochord, with cells in the most posterior portion of the notochord being the last to express it. As shown in Figs. 6A-6D , expression of the col2a1 gene was unchanged in the notochord of embryos treated with GA beginning at 50% epiboly and the cells exhibited the characteristic vacuolated, "stack of pennies" appearance . As well, down-regulation of col2a1 expression in the anteriormost mature cells of the notochord occurred in the same spatiotemporal pattern in both control and treated embryos, suggesting that the relative developmental age of these cells was unaffected. Furthermore, we were unable to detect any aberrant patterns in the expression of members of the hedgehog gene family, shh and ehh, which are expressed by the notochord early during embryogenesis and play critical roles in the patterning of the somites in zebrafish and other vertebrates (Krauss et al., 1993; Chiang et al., 1996; Currie and Ingham, 1996; Hammerschmidt et al., 1996; Blagden et al., 1997; Du et al., 1997; Figs. 6E-6H) , nor in the expression of other notochord-specific genes such as axial or no tail (data not shown). We did, however, observe that the notochord in GA-treated embryos sometimes developed folds, particularly at the location where the tail protrudes off the yolk, and the hypochord was present as only patches of cells along the A-P axis (see open arrows in Fig. 6D ). Expression of col2a1 (solid arrow in 6C and 6D) and shh (solid arrow in 6E and 6F) in the floor plate also appeared normal in GA-treated embryos, suggesting that early development of this tissue was also unaffected.
Muscle Pioneer Development Is Impaired in GA-Treated Embryos
The data presented thus far suggest that a specific GAHsp90 interaction disrupted development of one or more cell types of the paraxial mesoderm to give rise to the observed somite phenotype. In flh and ntl embryos, the somitic defects are thought to involve at least in part a failure of development of a group of slow muscle fibers known as the muscle pioneers. Muscle pioneers are the earliest muscle cells to differentiate in zebrafish, becoming morphologically distinct at around 13 h, simultaneous with somite differentiation (Felsenfeld et al., 1991) . About two to six muscle pioneers develop per somite at the future location of the horizontal myoseptum; they can be distinguished as they are the only muscle cells which express high levels of the engrailed-2 gene (Hatta et al., 1991; Ekker et al., 1992) . In all embryos examined by in situ hybridization, the eng-2-expressing muscle pioneers were either completely absent or severely reduced following GA treatment beginning at 50% epiboly (Fig. 7 , compare 7A and 7D with 7B and 7E). However, eng-2 expression at the midbrain/hindbrain boundary was unaffected, indicating that GA treatment did not result in general suppression of eng-2 activation throughout the embryo (asterisks in Figs. 7A, 7B, and 7C). These data indicate that GA prevented proper expression of the muscle pioneer phenotype in treated embryos.
The Hsp90-Dependent Step in Muscle Pioneer Formation Occurs Subsequent to Adaxial Cell Formation
Adaxial cells in zebrafish are the progenitors of both muscle pioneers and other slow muscle cells known as non-muscle-pioneer slow muscle and derive from paraxial mesoderm which lies directly adjacent to the notochord (Devoto et al., 1996; Du et al., 1997; Blagden et al., 1997) . These cells can be distinguished as they are the earliest cells which express myoD Devoto et al., 1996) ; their development is thought to involve, at least in part, suppression of protein kinase A (PKA) activity in somite cells by hedgehog signaling from the notochord (Devoto et al., 1996; Hammerschmidt et al., 1996; Ungar and Moon, 1996; Weinberg et al., 1996; Blagden et al., 1997; Du et al., 1997; Schauerte et al., 1998) . Forskolin, which raises intracellular levels of cAMP through its activation of the catalytic subunit of adenylate cyclase, has been used successfully to antagonize hedgehog activity in mouse in a manner similar to overexpression of constitutively active PKA (Fan et al., 1995) . As shown in Table 1 and Figs. 7C, 7F , and 8C, forskolin treatment of zebrafish embryos beginning at 50% epiboly resulted in a phenotype with a shortened body axis and complete inhibition of both eng-2-expressing muscle pioneer and myoD-expressing adaxial cell formation. In addition, forskolin treatment resulted in forebrain Anterior is to the left in all. Seventy-eight percent of the GA-treated embryos exhibited a shortened trunk/tail phenotype and the somites did not form their characteristic full chevron shape as described under Results (compare arrows in C and D, which indicate somites at comparable positions along the anterior-posterior axis). In addition, somites of treated embryos typically assumed a block-like shape and varied significantly in size within any one embryo (compare somites indicated by asterisks in E and F, which are the four most recently fully formed in both cases). The closely related benzoquinone ansamycin geldampicin, which is ineffective as an Hsp90-binding agent, had no detectable effect on embryonic development. In contrast to embryos treated with GA beginning at gastrulation, treatment initiated at the blastula stage was rapidly lethal. Scale bar in A-D, 100 m. Scale bar in E and F, 25 m. defects, such as fused eyes, which are also seen in embryos expressing constitutively active PKA (Hammerschmidt et al., 1996; Ungar and Moon, 1996) . In contrast, myoD expression in adaxial cells was unaffected by GA treatment (Fig. 8, compare 8B and 8C ). In the lateral presomitic cells, which later give rise to fast muscle fibers (Devoto et al., 1996) , myoD continued to be expressed in an apparently normal fashion following both GA and forskolin treatment.
In other experiments, we have found that GA treatment had no effect on the expression of several other early markers of adaxial cell formation including ␣-tropomyosin and snail-1 (data not shown). Thus, the GA-sensitive step during the formation of muscle pioneers exists downstream of the down-regulation of PKA activity and subsequent activation of myoD, ␣-tropomyosin, and snail-1 expression within developing adaxial cells of the somite.
DISCUSSION
We have investigated the requirement for members of the Hsp90 family of molecular chaperones during early development of the zebrafish using the Hsp90-binding agent, geldanamycin. Our data show that GA interacts in a highly specific and competable fashion with both the ␣ and the ␤ isoforms of zebrafish Hsp90 in vitro. Furthermore, we were unable to detect an interaction of GA with other zebrafish proteins, a result which is consistent with demonstrations of GA specificity in other organisms (see Introduction). While the interaction of GA with both Hsp90␣ and Hsp90␤ was not unexpected based on deduced amino acid sequence comparison of the mammalian GA-binding domain with the zebrafish proteins, to our knowledge experimental demonstration of the interaction of GA with both isoforms from In situ hybridization for the detection of eng-2 mRNA was carried out as described under Materials and Methods. All embryos are lateral views with anterior to the left and dorsal to the top. Muscle pioneers, which can be distinguished from other striated muscle cells by high levels of eng-2 expression, normally develop at the D-V midline of the myotome at the future location of the horizontal myoseptum (arrows in A and D) but are absent from this location in GA-treated and forskolin-treated embryos (arrows in E and F). However, activation of eng-2 expression in cells of the midbrain/hindbrain boundary is unaffected by GA or forskolin treatment (asterisks in A-C). Scale bar in A-C, 100 m. Scale bar in D-F, 20 m.
a single vertebrate has not been reported. The majority of biochemical studies of Hsp90 function have not differentiated between the two isoforms and, for the most part, they appear to be interchangeable with respect to their biochemical activities in vitro. However, they do exhibit some unique biochemical characteristics such as stability of dimer formation (Minami et al., 1991 (Minami et al., , 1994 Nemoto et al., 1995) , possible phosphorylation sites (Lees-Miller and Anderson, 1989) , and intracellular localization (Perdew et al., 1993) . Furthermore, they exhibit remarkably different patterns of expression, with hsp90␣ being strongly inducible following heat shock and other stresses and hsp90␤ being expressed more widely at normal growth temperatures (reviewed in Morange et al., 1997a,b) . In zebrafish, we have shown that the hsp90␣ gene is expressed during the normal development of somitic muscle cells but is not expressed as part of the mature muscle phenotype ( Fig. 3 ; Sass et al., 1996; C. C. Martin and P. H. Krone, unpublished data) . However, the gene is strongly inducible in all cells of the embryo following heat shock (Sass et al., 1996) . In contrast, the hsp90␤ gene is very weakly heat inducible (Krone and Sass, 1994; Sass et al., 1996) yet is expressed in a relatively wide range of tissues during normal development (Fig. 4) . Thus, it is possible that the two genes are responsible for different yet related cellular chaperone functions in vivo. Alternatively or in addition to this, the ability of embryos to differentially regulate expression of the two isoforms may allow for more precise control of Hsp90 activity in different cell types.
Embryos treated with GA exhibited several characteristic defects which support the occurrence of a specific interaction of GA with the ␣ and ␤ isoforms of Hsp90 in vivo. A number of results from this study and others argue in support of this. First, the degenerate PCR-based cloning strategy which we originally used to identify and clone Hsp90 cDNAs expressed in developing zebrafish embryos utilized primers designed around the highly conserved GA-binding amino terminus of Hsp90 from a wide range of species (Krone and Sass, 1994) . Indeed, the primers themselves corresponded to the two stretches of highest amino acid identity within this region, which are also constituents of the GA-binding pocket (Grenert et al., 1997; Stebbins et al., 1997) . Thus, the screen would have been expected to isolate other GA-binding members of the Hsp90 family which are expressed during embryogenesis, but only hsp90␣ and hsp90␤ were identified. Second, the defects correspond to tissues which express either the hsp90␣ or the hsp90␤ gene; tissues which do not express either of these genes at detectable levels, such as the notochord, are relatively unaffected (see also below). Third, treatment of embryos with geldampicin, a closely related analog of GA which is ineffective as an Hsp90 binding agent, had no effect. Thus, the phenotype is not caused by a toxic effect of benzoquinone ansamycins in general on development. Fourth, no other zebrafish proteins interacted with GA in a specific and competable fashion in our assay. Taken together with further evidence pertaining to defects in muscle pioneer development, these data provide strong support that the GA-induced embryonic defects are due to a specific interaction of GA with Hsp90␣ and Hsp90␤ in vivo.
While our experiments demonstrate that members of the zebrafish Hsp90 family are likely to play multiple roles during the development of different cell types and that Hsp90 is an essential protein for embryonic development, it is interesting that several tissues were relatively unaffected by GA treatment. Previous studies using yeast and cultured cells have shown that Hsp90 is an abundant protein in a variety of cell types, with some estimates indicating that it comprises up to 1-2% of the total cytosolic protein (reviewed in Csermely et al., 1998) . In yeast, a functional copy of the hsp90 gene is essential for survival (Borkovich et al., 1989) . These and other observations have led to the sugges- Adaxial cells (arrow) could be detected directly adjacent to the notochord prior to somitogenesis in both control and GA-treated embryos but did not form in embryos treated with forskolin. In contrast, the myoD-expressing lateral presomitic cells which will go on to form fast muscle fibers were normal in all three groups of embryos (asterisks in A-C). Treatment with GA and forskolin was initiated at 50% epiboly. Scale bar, 50 m.
tion that high levels of Hsp90 are essential for eukaryotic cell viability. However, the data obtained using GA treatment and that demonstrating spatiotemporal specificity of Hsp90 gene expression in this and other studies from our laboratory (Sass et al., 1996 ; J. B. Sass and P. H. Krone, unpublished) suggest that not all cells of the zebrafish embryo may require Hsp90 at all times for their proliferation and/or differentiation or that different cell types have dramatically different threshold requirements for Hsp90. For example, the notochord in GA-treated embryos developed normally, a result which is consistent with our inability to detect expression of either the hsp90␣ or the hsp90␤ gene in this tissue. Similarly, the apparently normal early development of adaxial cells is consistent with the fact that strong activation of hsp90␣ gene expression is not detectable within these cells until after the activation of myoD expression (Sass et al., 1996 ; J. B. Sass and P. H. Krone, unpublished) . An alternative explanation is that other chaperone molecules which exhibit Hsp90-like activities may substitute for Hsp90 in some cell types. For example, Cdc37 has recently been shown to have chaperone properties similar to those of Hsp90 yet has specific functions in signal transduction pathways which diverge in vivo (Kimura et al., 1997) . Distantly related members of the Hsp90 family have also been reported recently (hsp75 and TRAP-1; Song et al., 1995; Chen et al., 1996) ; based on comparative sequence analysis, GA would not be predicted to inhibit the activity of these molecules.
The GA-induced trunk/tail phenotype was typified by the presence of aberrations in shape and size of somites, a shortened trunk and tail, and disruption in proper muscle pioneer formation. Furthermore, the Hsp90-dependent process(es) defined in this study occurs downstream of both notochord development and subsequent formation of myoD-expressing adaxial cells, a subset of which gives rise to the muscle pioneers. Our data suggest that Hsp90, and most likely Hsp90␣ (see below), is required during the specification and/or differentiation of muscle pioneers from adaxial cells and that many of the signaling and differentiation events occurring in the pathway prior to this point appear to be unaffected. However, the data do not discount the possibility that Hsp90 also plays a role in the formation of other somitic muscle fiber cell types which differentiate later during formation of the zebrafish myotome (Devoto et al., 1996; Blagden et al., 1997) . For example, a subset of adaxial cells undergoes a wave of migration to the surface of the myotome after the 20-somite stage of development and forms a layer of superficial slow muscle fibers known as the non-muscle-pioneer slow muscle (Devoto et al., 1996; Blagden et al., 1997) . In contrast, fast muscle fibers are derived from the somitic cells which initially lie lateral to the adaxial cells and begin to differentiate after the wave of migration of the non-muscle-pioneer slow muscle has been completed. The fact that all adaxial cells as well as developing fast muscle fibers later in development strongly express the hsp90␣ gene (this study; Sass et al., 1996 ; C. C. Martin and P. H. Krone, unpublished) 
Several other pieces of evidence from this and other studies support the hypothesis that Hsp90 function is required during the formation of muscle pioneers from adaxial cells. First, the hsp90␣ gene is strongly expressed in adaxial cells under nonstress conditions (Sass et al., 1996; Fig. 3) . Importantly, hsp90␣ expression either coincides with or precedes the expression of other muscle regulatory genes such as myogenin and members of the MEF-2 family in these cells Sass et al., 1996; Ticho et al., 1996; J. B. Sass and P. H. Krone, unpublished) . Second, hsp90␣ expression is coordinately down-regulated with myoD following somitic striated muscle fiber differentiation as would be expected for a gene involved in fiber development but not the maintenance of the mature fiber phenotype (Sass et al., 1996) . Third, hsp90␣ expression is activated shortly following myoD in midline cells of flh mutants which would normally form notochord but are respecified to a paraxial mesoderm fate (J. B. Sass and P. H. Krone, unpublished) . These cells have been shown to express characteristics typical of adaxial cells Talbot et al., 1995; Melby et al., 1996; Blagden et al., 1997) . Fourth, Hsp90 interacts with a number of molecules involved in signal transduction pathways and the regulation of gene expression in other vertebrates, including several which play important roles during muscle development. In the latter category, biochemical studies have shown that murine Hsp90 can stimulate the DNA binding activity of MyoD in vitro (Shaknovich et al., 1992; Shue and Kohtz, 1994) . While the precise role of MyoD in zebrafish muscle development has yet to be elucidated, it is likely to play a fundamental role in this process given its importance in other vertebrates (recently reviewed in Firulli and Olson, 1997; Rawls and Olson, 1997) as well as its pattern of expression in zebrafish . Hsp90 also interacts with casein kinase II, which has recently been implicated as a potential regulator of MyoD activity during mammalian myogenesis (Johnson et al., 1996) . Interestingly, we have recently reported that hsp90␣ mRNA is also enriched in the developing somites of chicken embryos , a result which suggests that elevated levels of Hsp90 are required for aspects of muscle development in other vertebrates as well. Rutherford and Lindquist (1998) recently showed that impairment of Hsp90 function in Drosophila, by both mutagenesis and feeding of GA, resulted in the appearance of a wide array of morphological variations in a small but significant number of different lines of adult flies. Interestingly, upon selection the traits uncovered in each line became independent of Hsp90 function. The authors suggest that Hsp90 may function as a molecular capacitor for evolution whereby transient decreases in Hsp90 levels cause the appearance of stress-damaged proteins requiring Hsp90 chaperone activity. The titration of Hsp90 by these proteins can then uncover variants in signaling molecules for selection to act upon. Whether such a mechanism exists in vertebrates, which express two different Hsp90 genes, is not known. However, the consistency and penetrance (almost 80%) of the GA-induced phenotype in zebrafish embryos indicates that we are not observing a similar mechanism at work in the present study. Further, we have observed the same phenotype and high penetrance in embryos obtained from different wild-type sources, a result not seen in the Drosophila study. Indeed, the data presented here support the suggestion that Hsp90 isoforms in zebrafish embryos may not simply provide housekeeping chaperone function to all cells and tissues, but rather may fulfill more specific roles in allowing some cell types to respond to or interpret signal transduction events.
